Details

Autor(en) / Beteiligte

• Lievre, Michel
• Menard, Joel
• Bruckert, Eric
• Cogneau, Joel

Titel

Premature discontinuation of clinical trial for reasons not related to efficacy, safety, or feasibility / Commentary

Ist Teil von

• BMJ. British medical journal (International ed.), 2001-03, Vol.322 (7286), p.603

Auflage

International edition

Ort / Verlag

London: BMJ Publishing Group

Erscheinungsjahr

2001

Quelle

Applied Social Sciences Index & Abstracts (ASSIA)

Beschreibungen/Notizen

• Competing interests: ML has been reimbursed by Novartis for attending a congress; his department benefited from a contract with Novartis for the study data management and analysis EB has received fees for speaking and reimbursement for attending symposiums from different pharmaceutical companies. PG has been reimbursed by Novartis, Bristol Meyers Squibb, and Parke Davis for attending several conferences and has received fees from Novartis, Parke Davis, and Fournier for speaking in educational programmes.